Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Delcath Systems, Inc.(DCTH) | 3,300,389 | 3,300,389 | 0 | $30.63M | $41.55M | 15.61% | +$10.92M |
| Fennec Pharmaceuticals Inc.(FENC) | 2,908,201 | 3,188,001 | +279,800 | $17.89M | $34.27M | 12.87% | +$16.39M |
| Xeris Biopharma Holdings Inc | 3,231,700 | 2,908,981 | -322,719 | $18.74M | $23.04M | 8.65% | +$4.30M |
| Savara Inc.(SVRA) | 3,203,721 | 3,178,121 | -25,600 | $17.49M | $19.58M | 7.35% | +$2.08M |
| Verastem, Inc.(VSTM) | 2,138,475 | 3,986,509 | +1,848,034 | $11.33M | $15.23M | 5.72% | +$3.89M |
| X4 Pharmaceuticals, Inc.(XFOR) | 3,214,766 | 3,214,766 | 0 | $13.28M | $15.01M | 5.64% | +$1.74M |
| EyePoint, Inc.(EYPT) | 1,036,737 | 988,230 | -48,507 | $13.36M | $14.13M | 5.31% | +$768.1K |
| Cybin D/B/A Helus Pharma(HELP) | 1,531,814 | 1,956,814 | +425,000 | $7.35M | $12.93M | 4.86% | +$5.58M |
| Vor Biopharma Inc.(VOR) | 700,000 | 648,600 | -51,400 | $12.49M | $11.94M | 4.49% | -$547.3K |
| Vaxcyte, Inc.(PCVX) | 290,000 | 200,000 | -90,000 | $16.85M | $11.63M | 4.37% | -$5.23M |
| MediWound Ltd.SHS NEW(MDWD) | 749,054 | 749,054 | 0 | $12.07M | $11.01M | 4.14% | -$1.06M |
| Celldex Therapeutics, Inc.(CLDX) | 330,000 | 200,000 | -130,000 | $10.47M | $7.44M | 2.80% | -$3.03M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 923,057 | 721,504 | -201,553 | $8.79M | $7.22M | 2.71% | -$1.57M |
| Profound Medical Corp.(PROF) | 828,118 | 828,118 | 0 | $5.37M | $5.51M | 2.07% | +$140.8K |
| Talphera, Inc.(TLPH) | 3,353,916 | 5,169,501 | +1,815,585 | $2.51M | $5.32M | 2.00% | +$2.82M |
| Atea Pharmaceuticals, Inc.(AVIR) | 1,171,855 | 1,070,550 | -101,305 | $6.30M | $4.98M | 1.87% | -$1.33M |
| Myomo, Inc.(MYO) | 3,847,272 | 3,637,886 | -209,386 | $2.60M | $3.78M | 1.42% | +$1.18M |
| Ovid Therapeutics Inc.(OVID) | 1,107,994 | 1,107,994 | 0 | $2.46M | $2.98M | 1.12% | +$520.8K |
| NeurAxis, Inc.(NRXS) | 286,138 | 508,055 | +221,917 | $1.69M | $2.97M | 1.12% | +$1.28M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 20,869 | +20,869 | $0 | $2.78M | 1.04% | +$2.78M |
| InspireMD, Inc.(NSPR) | 3,905,743 | 3,905,743 | 0 | $6.37M | $2.73M | 1.03% | -$3.63M |
| Regentis Biomaterials Ltd.(RGNT) | 251,510 | 701,685 | +450,175 | $768.4K | $2.48M | 0.93% | +$1.71M |
| PolyPid Ltd.(PYPD) | 597,926 | 389,455 | -208,471 | $2.62M | $1.98M | 0.74% | -$640.5K |
| Biofrontera Inc.(BFRI) | 1,163,962 | 1,275,609 | +111,647 | $941.6K | $1.21M | 0.45% | +$264.4K |
| Kura Oncology, Inc.(KURA) | 100,000 | 100,000 | 0 | $813.0K | $1.10M | 0.41% | +$284.0K |
| Spruce Biosciences Inc | 0 | 20,000 | +20,000 | $0 | $1.08M | 0.41% | +$1.08M |
| Aquestive Therapeutics Inc | 250,000 | 250,000 | 0 | $1.04M | $1.04M | 0.39% | +$2.5K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 443,763 | 150,000 | -293,763 | $1.84M | $684.0K | 0.26% | -$1.15M |
| PepGen Inc.(PEPG) | 0 | 350,000 | +350,000 | $0 | $630.0K | 0.24% | +$630.0K |
| Annexon, Inc.(ANNX) | 200,000 | 0 | -200,000 | $1.11M | $0 | — | -$1.11M |
| Avalo Therapeutics, Inc.(AVTX) | 75,000 | 0 | -75,000 | $1.12M | $0 | — | -$1.12M |
| CG Oncology, Inc.(CGON) | 100,000 | 0 | -100,000 | $6.77M | $0 | — | -$6.77M |
| Definium Therapeutics, Inc.(DFTX) | 125,000 | 0 | -125,000 | $2.36M | $0 | — | -$2.36M |
| Lipocine Inc.(LPCN) | 221,616 | 0 | -221,616 | $1.77M | $0 | — | -$1.77M |
| Viridian Therapeutics, Inc.(VRDN) | 250,401 | 0 | -250,401 | $4.90M | $0 | — | -$4.90M |